Stocks

The table gives an overview of all stocks, alphabetically sorted.
 X Financial American Depositary Shares, each representing si XYF Mar 1, 2021 3.49 +1.16   
 X4 Pharmaceuticals, Inc. XFOR Mar 1, 2021 9.90 +3.45   
 XAI Octagon Floating Rate & Alternative Income Term Trust XFLT Mar 1, 2021 8.64 +2.86   
 XBiotech Inc XBIT Mar 1, 2021 19.47 +2.47   
 Xcel Brands, Inc XELB Mar 1, 2021 1.84 +5.14   
 Xcel Energy Inc. XEL Mar 1, 2021 59.15 +0.96   
 Xencor, Inc. XNCR Mar 1, 2021 48.33 -1.91   
 Xenetic Biosciences, Inc. XBIO Mar 1, 2021 2.52 +5.44   
 Xenia Hotels & Resorts, Inc. XHR Mar 1, 2021 18.79 -5.91   
 Xenon Pharmaceuticals Inc. - XENE Mar 1, 2021 17.92 -4.07   
 Xeris Pharmaceuticals, Inc. XERS Mar 1, 2021 5.40 -0.92   
 Xerox Holdings Corporation XRX Mar 1, 2021 25.77 +1.14   
 Xiaobai Maimai Inc. - American Depositary Shares HX Mar 1, 2021 1.93 +10.92   
 Xilinx, Inc. XLNX Mar 1, 2021 133.79 +2.68   
 Xinyuan Real Estate Co Ltd American Depositary Shares XIN Mar 1, 2021 2.83 +1.80   
 XL Fleet Corp. Class A XL Mar 1, 2021 14.85 0.00   
 XOMA Corporation XOMA Mar 1, 2021 37.10 +2.49   
 XOMA Corporation - 8.625% Series A Cumulative Perpetual Pref XOMAP Mar 1, 2021 25.57 0.00   
 XP Inc. - Class A Common Stock XP Mar 1, 2021 44.12 -0.05   
 XPEL, Inc. XPEL Mar 1, 2021 52.19 +7.94   
 XPeng Inc. American depositary shares, each representing two XPEV Mar 1, 2021 35.50 +4.08   
 Xperi Holding Corporation XPER Mar 1, 2021 21.10 0.00   
 XPO Logistics Inc XPO Mar 1, 2021 119.66 +2.62   
 XpresSpa Group, Inc. XSPA Mar 1, 2021 1.82 +3.41   
 Xtant Medical Holdings Inc XTNT Mar 1, 2021 4.09 -5.54   
 XTL Biopharmaceuticals Ltd. - American Depositary Shares XTLB Mar 1, 2021 3.22 +3.87   
 Xunlei Limited - American Depositary Shares XNET Mar 1, 2021 7.31 +11.94   
 Xylem Inc. XYL Mar 1, 2021 102.23 +2.68   
 Y-mAbs Therapeutics, Inc. YMAB Mar 1, 2021 35.72 +1.56   
 Yalla Group Limited YALA Mar 1, 2021 25.75 +18.61   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK